Company News: SuppreMol Appoints Dr. Robert Phelps as Head of Business Development & Licensing

Monday, February 8, 2010

SuppreMol GmbH, a privately held biopharmaceutical company developing novel therapeutics for the treatment of autoimmune diseases, today announced that Dr. Robert Phelps has joined the Company as Head of Business Development & Licensing.

See the full release at SupperMol´s website.

By akampion Posted in Company News

You can follow any responses to this entry through the RSS 2.0 feed No Comments You can leave a response, or trackback from your own site.

« Company News: Indivumed to Study the Integrity of Biospecimen Sampling Procedures for the U.S. National Cancer Institute

Food for Thought: An Artificial Tree to Remove CO2 from the Atmosphere »

In order to submit a comment, you need to mention your name and your email address (which won't be published). And ... don't forget your comment!